PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy) is a promising treatment option for patients with peritoneal surface cancers. These are aggressive cancers that have spread to the lining of the abdomen and are often resistant to traditional chemotherapy. Dr. Ashwin K.R., HOD - Surgical Oncology at Aster Whitefield Hospital explains about the PIPAC treatment in this video blog.
How PIPAC Works?
- Direct Delivery: Unlike traditional chemotherapy that circulates through the entire body, PIPAC delivers the treatment directly to the cancer cells within the abdominal cavity.
- Pressurized Aerosol: The chemotherapy is administered as a fine mist, ensuring better coverage of the peritoneal surface and potentially improved drug penetration into tumor tissues.
- Daycare Procedure: PIPAC is a minimally invasive procedure that can be performed on an outpatient basis, reducing the burden on patients compared to traditional hospital stays.
Benefits of PIPAC:
- Improved Efficacy: By directly targeting cancer cells in the abdomen, PIPAC has shown potential for better tumor response rates compared to conventional chemotherapy.
- Reduced Side Effects: Since the chemotherapy is confined to the abdomen, patients may experience fewer systemic side effects often associated with traditional chemotherapy.
- Combination Therapy: PIPAC can be used in conjunction with other treatments, such as surgery, to enhance overall treatment outcomes.
While PIPAC shows promise, it's essential to consult with a qualified medical professional to determine if it is a suitable treatment option for individual patients. For more information, consult our experts at Aster Whitefield Hospital.
To book an appointment, contact us at 080-4510 8888.
